Research Collaboration
A strong signal of the internationally renowned lipid research in Graz: In cooperation of University of Graz and Graz University of Technology, scientists have developed a molecule that inhibits the fat-degrading enzyme ATGL in mice. It's called Atglistatin®.
Intellectual Property Rights
The molecule Atglistatin® is the subject of the patent US9206115, which was granted in 2015. Additionally, the term "Atglistatin®" is registered as a trademark in the United States and the European Union.
Atglistatin® is a registered trademark of University of Graz.
Correct Citation
Scientific publication to be referenced when using Atglistatin®:
Mayer, N., Schweiger, M., Romauch, M., Grabner, G., Eichmann, T., Fuchs, E., Ivkovic, J., Heier, C., Mrak, I., Lass, A., Höfler, G., Fledelius, C., Zechner, R., Zimmermann, R. & Breinbauer, R.: Development of small-molecule inhibitors targeting adipose triglyceride lipase. Nature Chemical Biology, 2013, 9, 785-787. doi:10.1038/nchembio.1359